Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine.
Dayan GH, Rouphael N, Walsh SR, Chen A, Grunenberg N, Allen M, Antony J, Asante KP, Bhate AS, Beresnev T, Bonaparte MI, Ceregido MA, Dobrianskyi D, Fu B, Grillet MH, Keshtkar-Jahromi M, Juraska M, Kee JJ, Kibuuka H, Koutsoukos M, Masotti R, Michael NL, Reynales H, Robb ML, Villagómez Martínez SM, Sawe F, Schuerman L, Tong T, Treanor J, Wartel TA, Diazgranados CA, Chicz RM, Gurunathan S, Savarino S, Sridhar S; VAT00008 study team. Dayan GH, et al. Among authors: robb ml. medRxiv [Preprint]. 2023 Jan 13:2022.12.05.22282933. doi: 10.1101/2022.12.05.22282933. medRxiv. 2023. PMID: 36523415 Free PMC article. Preprint.
IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens.
Karasavvas N, Karnasuta C, Savadsuk H, Madnote S, Inthawong D, Chantakulkij S, Rittiroongrad S, Nitayaphan S, Pitisuttithum P, Thongcharoen P, Siriyanon V, Andrews CA, Barnett SW, Tartaglia J, Sinangil F, Francis DP, Robb ML, Michael NL, Ngauy V, de Souza MS, Paris RM, Excler JL, Kim JH, O'Connell RJ; MOPH-TAVEG Collaboration. Karasavvas N, et al. Among authors: robb ml. AIDS Res Hum Retroviruses. 2015 Nov;31(11):1178-86. doi: 10.1089/AID.2015.0034. Epub 2015 Sep 9. AIDS Res Hum Retroviruses. 2015. PMID: 26234467 Free PMC article. Clinical Trial.
Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting.
Marichannegowda MH, Zemil M, Wieczorek L, Sanders-Buell E, Bose M, O'Sullivan AM, King D, Francisco L, Diaz-Mendez F, Setua S, Chomont N, Phanuphak N, Ananworanich J, Hsu D, Vasan S, Michael NL, Eller LA, Tovanabutra S, Tagaya Y, Robb ML, Polonis VR, Song H. Marichannegowda MH, et al. Among authors: robb ml. bioRxiv [Preprint]. 2023 Jan 22:2023.01.21.525033. doi: 10.1101/2023.01.21.525033. bioRxiv. 2023. Update in: EBioMedicine. 2023 Dec;98:104867. doi: 10.1016/j.ebiom.2023.104867. PMID: 36712089 Free PMC article. Updated. Preprint.
Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype.
Marichannegowda MH, Setua S, Bose M, Sanders-Buell E, King D, Zemil M, Wieczorek L, Diaz-Mendez F, Chomont N, Thomas R, Francisco L, Eller LA, Polonis VR, Tovanabutra S, Tagaya Y, Michael NL, Robb ML, Song H. Marichannegowda MH, et al. Among authors: robb ml. bioRxiv [Preprint]. 2023 Sep 15:2023.09.15.557832. doi: 10.1101/2023.09.15.557832. bioRxiv. 2023. Update in: EBioMedicine. 2024 Nov;109:105410. doi: 10.1016/j.ebiom.2024.105410. PMID: 37745406 Free PMC article. Updated. Preprint.
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical Trial.
Ake JA, Paolino K, Hutter JN, Cicatelli SB, Eller LA, Eller MA, Costanzo MC, Paquin-Proulx D, Robb ML, Tran CL, Anova L, Jagodzinski LL, Ward LA, Kilgore N, Rusnak J, Bounds C, Badorrek CS, Hooper JW, Kwilas SA, Ilsbroux I, Anumendem DN, Gaddah A, Shukarev G, Bockstal V, Luhn K, Douoguih M, Robinson C. Ake JA, et al. Among authors: robb ml. Vaccines (Basel). 2024 May 4;12(5):497. doi: 10.3390/vaccines12050497. Vaccines (Basel). 2024. PMID: 38793748 Free PMC article.
Bayesian estimation of HIV acquisition dates for prevention trials.
Rossenkhan R, Giorgi EE, Shao D, Ludwig J, Labuschagne P, Magaret CA, Ndung'u T, Muema D, Gounder K, Dong KL, Walker BD, Rolland M, Robb ML, Eller LA, Sawe F, Nitayaphan S, Grebe E, Busch MP, Delaney KP, Facente S, Carpp LN, deCamp AC, Huang Y, Korber B, Juraska M, Rudnicki E, Kosmider E, Reeves DB, Mayer BT, Hural J, Deng W, Westfall DH, Yssel A, Matten D, Bhattacharya T, Corey L, Gilbert PB, Williamson C, Mullins JI, Edlefsen PT. Rossenkhan R, et al. Among authors: robb ml. mBio. 2025 Sep 9:e0188125. doi: 10.1128/mbio.01881-25. Online ahead of print. mBio. 2025. PMID: 40923785 Free article.
High peak viraemia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East Africa.
Li Y, Dearlove BL, Lewitus E, Bai H, Shangguan S, Pham P, Bose M, Sanders-Buell E, Miller SH, Rosario Y, Ehrenberg PK, Tovanabutra S, Thomas R, Ake JA, Vasan S, Eller LA, Nitayaphan S, Maganga L, Kibuuka H, Sawe FK, Robb ML, Rolland M. Li Y, et al. Among authors: robb ml. J Int AIDS Soc. 2025 Aug;28(8):e70016. doi: 10.1002/jia2.70016. J Int AIDS Soc. 2025. PMID: 40879355 Free PMC article.
Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohorts.
Ehrenberg PK, Geretz A, Volcic M, Izumi T, Yum LK, Waickman A, Shangguan S, Paquin-Proulx D, Creegan M, Bose M, Machmach K, McGraw A, Narahari A, Currier JR, Sacdalan C, Phanuphak N, Apps R, Corley M, Ndhlovu LC, Slike B, Krebs SJ, Anonworanich J, Tovanabutra S, Robb ML, Eller MA, Laird GM, Cyktor J, Daar ES, Crowell TA, Mellors JW, Vasan S, Michael NL, Kirchhoff F, Thomas R. Ehrenberg PK, et al. Among authors: robb ml. Nat Commun. 2025 May 29;16(1):4975. doi: 10.1038/s41467-025-59833-9. Nat Commun. 2025. PMID: 40442100 Free PMC article.
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials.
Andrews LIB, Halloran ME, Neuzil KM, van der Laan L, Huang Y, Andriesen J, Patel M, Fisher LH, Janes H, Rouphael N, Walsh SR, Theodore DA, Tieu HV, Sobieszczyk M, El Sahly HM, Baden LR, Falsey AR, Campbell TB, Kelley CF, Healy CM, Immergluck L, Luft B, Hirsch I, de Bruyn G, Truyers C, Priddy F, Sumner KM, Flannery B, Follmann D, Gilbert PB; COVID-19 Prevention Network (CoVPN). Andrews LIB, et al. JAMA Netw Open. 2025 May 1;8(5):e2512763. doi: 10.1001/jamanetworkopen.2025.12763. JAMA Netw Open. 2025. PMID: 40434773 Free PMC article.
NK cell activation and CD4+ T cell α4β7 expression are associated with susceptibility to HIV-1.
Machmach K, N'guessan KF, Farmer R, Godbole S, Kim D, McCormick L, Lima NS, Henry AR, Laboune F, Swafford I, Mika SK, Slike BM, Currier JR, Eller LA, Ake JA, Vasan S, Robb ML, Krebs SJ, Douek DC, Paquin-Proulx D; RV217 Study Group. Machmach K, et al. Among authors: robb ml. J Clin Invest. 2025 May 8;135(15):e187992. doi: 10.1172/JCI187992. eCollection 2025 Aug 1. J Clin Invest. 2025. PMID: 40338667 Free PMC article.
415 results